Development of an oxygen-sensitive degradable peptide probe for the imaging of hypoxia-inducible factor-1-active regions in tumors
- PMID: 23689986
- DOI: 10.1007/s11307-013-0647-6
Development of an oxygen-sensitive degradable peptide probe for the imaging of hypoxia-inducible factor-1-active regions in tumors
Abstract
Purpose: We aimed to develop a radiolabeled peptide probe for the imaging of hypoxia-inducible factor-1 (HIF-1)-active tumors.
Procedures: We synthesized the peptide probes that contain or lack an essential sequence of the oxygen-dependent degradation of HIF-1α in proteasomes ((123/125)I-DKOP30 or (125)I-mDKOP, respectively). The degradation of probes was evaluated in vitro using cell lysates containing proteasomes. In vivo biodistribution study, planar imaging, autoradiography, and comparison between probe accumulation and HIF-1 transcriptional activity were also performed.
Results: The (125)I-DKOP30 underwent degradation in a proteasome-dependent manner, while (125)I-mDKOP was not degraded. Biodistribution analysis showed (125)I-DKOP30 accumulation in tumors. The tumors were clearly visualized by in vivo imaging, and intratumoral distribution of (125)I-DKOP30 coincided with the HIF-1α-positive hypoxic regions. Tumoral accumulation of (125)I-DKOP30 was significantly correlated with HIF-1-dependent luciferase bioluminescence, while that of (125)I-mDKOP was not.
Conclusion: (123)I-DKOP30 is a useful peptide probe for the imaging of HIF-1-active tumors.
Similar articles
-
Radiolabeled probes targeting hypoxia-inducible factor-1-active tumor microenvironments.ScientificWorldJournal. 2014;2014:165461. doi: 10.1155/2014/165461. Epub 2014 Aug 18. ScientificWorldJournal. 2014. PMID: 25215311 Free PMC article. Review.
-
Imaging of HIF-1-active tumor hypoxia using a protein effectively delivered to and specifically stabilized in HIF-1-active tumor cells.J Nucl Med. 2009 Jun;50(6):942-9. doi: 10.2967/jnumed.108.061119. Epub 2009 May 14. J Nucl Med. 2009. PMID: 19443598
-
Evaluation of [125I]IPOS as a molecular imaging probe for hypoxia-inducible factor-1-active regions in a tumor: comparison among single-photon emission computed tomography/X-ray computed tomography imaging, autoradiography, and immunohistochemistry.Cancer Sci. 2011 Nov;102(11):2090-6. doi: 10.1111/j.1349-7006.2011.02057.x. Epub 2011 Sep 15. Cancer Sci. 2011. PMID: 21824221
-
In vivo visualization of heterogeneous intratumoral distribution of hypoxia-inducible factor-1α activity by the fusion of high-resolution SPECT and morphological imaging tests.J Biomed Biotechnol. 2012;2012:262741. doi: 10.1155/2012/262741. Epub 2012 Jun 12. J Biomed Biotechnol. 2012. PMID: 22778544 Free PMC article.
-
[Development of a method of high-contrasted nuclear medical imaging of hypoxia-inducible factor-1-active tumor by using a pretargeting approach].Yakugaku Zasshi. 2012;132(5):595-600. doi: 10.1248/yakushi.132.595. Yakugaku Zasshi. 2012. PMID: 22687695 Review. Japanese.
Cited by
-
Gallium-68-labeled anti-HER2 single-chain Fv fragment: development and in vivo monitoring of HER2 expression.Mol Imaging Biol. 2015 Feb;17(1):102-10. doi: 10.1007/s11307-014-0769-5. Mol Imaging Biol. 2015. PMID: 25049073
-
Radionuclide imaging and therapy directed towards the tumor microenvironment: a multi-cancer approach for personalized medicine.Eur J Nucl Med Mol Imaging. 2022 Nov;49(13):4616-4641. doi: 10.1007/s00259-022-05870-1. Epub 2022 Jul 5. Eur J Nucl Med Mol Imaging. 2022. PMID: 35788730 Free PMC article. Review.
-
Radiolabeled probes targeting hypoxia-inducible factor-1-active tumor microenvironments.ScientificWorldJournal. 2014;2014:165461. doi: 10.1155/2014/165461. Epub 2014 Aug 18. ScientificWorldJournal. 2014. PMID: 25215311 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources